WindMIL Therapeutics, a clinical-stage company developing marrow-infiltrating lymphocytes (MILs) for cancer immunotherapy, and Cognate BioServices, a contract development and manufacturing organization (CDMO) ...
WindMIL Therapeutics has entered into a new clinical research collaboration with Bristol-Myers Squibb Company to evaluate the safety and efficacy of ...